https://www.selleckchem.com/pr....oducts/srt2104-gsk22
Clinical data comparing diagnostic strategies in the management of -associated diseases are limited. Invasive and noninvasive diagnostic tests for detecting infection are used in the clinical care of patients with dyspeptic symptoms. Modelling studies might help to identify the most cost-effective strategies. The objective of the study is to assess the cost-effectiveness of a 'test-and-treat' strategy with the urea breath test (UBT) compared with other strategies, in managing patients with -associated dyspepsia and preventing